Cell fate commitment involved in pattern specification
associated omics data
GO:0060581Ontology (GO BP)GO biological process · ~11 member genes
Q-omics provides the Cell fate commitment involved in pattern specification (GO:0060581) pathway profile, scoring each patient from the combined activity of its roughly 11 member genes. Pathway activity is associated with patient survival in 21 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, the pathway is differentially active in 9, with the highest sampling consensus in KIRC. Additionally, pathway RNA activity shows 29,363 significant cross-omics associations, again with the highest sampling consensus in OV. Together, these results highlight KIRC, and OV as cancer lineages where the pathway shows reproducible signals across outcome, tissue activity, and molecular association analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns. Pathway-against-pathway and pathway-against-mutation comparisons are not available for ontology entities.
Survival associations
This table summarizes Cell fate commitment involved in pattern specification survival associations by molecular data type. RNA-level pathway activity shows survival associations in the most cancer types (21). The rightmost column indicates the cancer type with the highest sampling consensus for each layer.
This table ranks reproducible pathway activity–survival associations across cancer types. High Cell fate commitment involved in pattern specification activity shows favorable associations in KIRC, but unfavorable associations in READ, LAML, LUAD, LIHC and THCA. In the KIRC Kaplan–Meier curve the low-activity group declines faster, consistent with the favorable association (log-rank p < 0.001). KIRC ranks highest by sampling consensus for Cell fate commitment involved in pattern specification.
This table summarizes Cell fate commitment involved in pattern specification tumor–normal activity differences by data type. RNA-level activity shows significant tumor–normal differences in 9 cancer types, while mass-spec protein activity shows differences in 4. The strongest signals are in KIRC for RNA and HNSC for protein.
This table ranks reproducible tumor–normal activity differences for the pathway. A positive fold-change indicates higher activity in tumor tissue. The pathway shows higher tumor activity across KIRC, HNSC, LIHC and KICH and lower tumor activity in BLCA and UCEC. In the KIRC box plot, tumor samples show higher pathway activity than matched normal samples (log2 FC = +0.080, t-test p < 0.001).
This table shows molecular features associated with Cell fate commitment involved in pattern specification pathway activity in patient tissues and cancer cell lines. In patient samples, pathway activity is most strongly linked to RNA and protein features, with the largest associated set in OV. In cancer cell lines, RNA-expression features and functional dependencies dominate, with the largest set in UPPER_AERODIGESTIVE_TRACT.
